메뉴 건너뛰기




Volumn 13, Issue , 2013, Pages

Investigating the safety and efficacy of naltrexone for anti-psychotic induced weight gain in severe mental illness: Study protocol of a double-blind, randomized, placebo-controlled trial

Author keywords

Antipsychotics; Metabolic Syndrome; Naltrexone; Obesity; Schizophrenia; Severe Mental Illness; Weight Loss

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 6; LIPID; NALTREXONE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA;

EID: 84879432384     PISSN: None     EISSN: 1471244X     Source Type: Journal    
DOI: 10.1186/1471-244X-13-176     Document Type: Article
Times cited : (16)

References (62)
  • 1
    • 79952313121 scopus 로고    scopus 로고
    • Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?
    • 3051021, 21242060
    • Phutane VH, Tek C, Chwastiak L, Ratliff JC, Ozyuksel B, Woods SW, Srihari VH. Cardiovascular risk in a first-episode psychosis sample: a 'critical period' for prevention?. Schizophr Res 2011, 127(1-3):257-261. 3051021, 21242060.
    • (2011) Schizophr Res , vol.127 , Issue.1-3 , pp. 257-261
    • Phutane, V.H.1    Tek, C.2    Chwastiak, L.3    Ratliff, J.C.4    Ozyuksel, B.5    Woods, S.W.6    Srihari, V.H.7
  • 2
    • 68949101413 scopus 로고    scopus 로고
    • The unchanging mortality gap for people with schizophrenia
    • 10.1016/S0140-6736(09)61072-2, 19595448
    • Chwastiak LA, Tek C. The unchanging mortality gap for people with schizophrenia. Lancet 2009, 374(9690):590-592. 10.1016/S0140-6736(09)61072-2, 19595448.
    • (2009) Lancet , vol.374 , Issue.9690 , pp. 590-592
    • Chwastiak, L.A.1    Tek, C.2
  • 3
    • 84875803407 scopus 로고    scopus 로고
    • Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness
    • 10.1016/j.psym.2012.03.001, 22664309
    • Ratliff JC, Palmese LB, Reutenauer EL, Srihari VH, Tek C. Obese schizophrenia spectrum patients have significantly higher 10-year general cardiovascular risk and vascular ages than obese individuals without severe mental illness. Psychosomatics 2013, 54(1):67-73. 10.1016/j.psym.2012.03.001, 22664309.
    • (2013) Psychosomatics , vol.54 , Issue.1 , pp. 67-73
    • Ratliff, J.C.1    Palmese, L.B.2    Reutenauer, E.L.3    Srihari, V.H.4    Tek, C.5
  • 4
    • 35348960372 scopus 로고    scopus 로고
    • Severe mental illness and risk of cardiovascular disease
    • 10.1001/jama.298.15.1794, 17940236
    • Newcomer JW, Hennekens CH. Severe mental illness and risk of cardiovascular disease. JAMA 2007, 298(15):1794-1796. 10.1001/jama.298.15.1794, 17940236.
    • (2007) JAMA , vol.298 , Issue.15 , pp. 1794-1796
    • Newcomer, J.W.1    Hennekens, C.H.2
  • 5
    • 7444267835 scopus 로고    scopus 로고
    • Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness
    • 10.1176/appi.ps.55.11.1250, 2759895, 15534013
    • Jones DR, Macias C, Barreira PJ, Fisher WH, Hargreaves WA, Harding CM. Prevalence, severity, and co-occurrence of chronic physical health problems of persons with serious mental illness. Psychiatr Serv 2004, 55(11):1250-1257. 10.1176/appi.ps.55.11.1250, 2759895, 15534013.
    • (2004) Psychiatr Serv , vol.55 , Issue.11 , pp. 1250-1257
    • Jones, D.R.1    Macias, C.2    Barreira, P.J.3    Fisher, W.H.4    Hargreaves, W.A.5    Harding, C.M.6
  • 6
    • 1342286183 scopus 로고    scopus 로고
    • Bipolar disorder, obesity, and pharmacotherapy-associated weight gain
    • 10.4088/JCP.v64n1205, 14728103
    • Keck PE, McElroy SL. Bipolar disorder, obesity, and pharmacotherapy-associated weight gain. J Clin Psychiatry 2003, 64(12):1426-1435. 10.4088/JCP.v64n1205, 14728103.
    • (2003) J Clin Psychiatry , vol.64 , Issue.12 , pp. 1426-1435
    • Keck, P.E.1    McElroy, S.L.2
  • 7
    • 68949172254 scopus 로고    scopus 로고
    • 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study)
    • 10.1016/S0140-6736(09)60742-X, 19595447
    • Tiihonen J, Lonnqvist J, Wahlbeck K, Klaukka T, Niskanen L, Tanskanen A, Haukka J. 11-year follow-up of mortality in patients with schizophrenia: a population-based cohort study (FIN11 study). Lancet 2009, 374(9690):620-627. 10.1016/S0140-6736(09)60742-X, 19595447.
    • (2009) Lancet , vol.374 , Issue.9690 , pp. 620-627
    • Tiihonen, J.1    Lonnqvist, J.2    Wahlbeck, K.3    Klaukka, T.4    Niskanen, L.5    Tanskanen, A.6    Haukka, J.7
  • 9
  • 11
    • 33847713720 scopus 로고    scopus 로고
    • Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials
    • 10.4088/JCP.0207e04, 17335312
    • Lieberman JA. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia: efficacy, safety and cost outcomes of CATIE and other trials. J Clin Psychiatry 2007, 68(2):e04. 10.4088/JCP.0207e04, 17335312.
    • (2007) J Clin Psychiatry , vol.68 , Issue.2
    • Lieberman, J.A.1
  • 13
    • 0035029445 scopus 로고    scopus 로고
    • The pharmacology of weight gain with antipsychotics
    • Casey DE, Zorn SH. The pharmacology of weight gain with antipsychotics. J Clin Psychiatry 2001, 62(Suppl 7):4-10.
    • (2001) J Clin Psychiatry , vol.62 , Issue.SUPPL. 7 , pp. 4-10
    • Casey, D.E.1    Zorn, S.H.2
  • 14
    • 16544377948 scopus 로고    scopus 로고
    • Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients
    • 10.4088/JCP.v65n1007, 15491236
    • Arranz B, Rosel P, Ramirez N, Duenas R, Fernandez P, Sanchez JM, Navarro MA, San L. Insulin resistance and increased leptin concentrations in noncompliant schizophrenia patients but not in antipsychotic-naive first-episode schizophrenia patients. J Clin Psychiatry 2004, 65(10):1335-1342. 10.4088/JCP.v65n1007, 15491236.
    • (2004) J Clin Psychiatry , vol.65 , Issue.10 , pp. 1335-1342
    • Arranz, B.1    Rosel, P.2    Ramirez, N.3    Duenas, R.4    Fernandez, P.5    Sanchez, J.M.6    Navarro, M.A.7    San, L.8
  • 17
    • 81455130784 scopus 로고    scopus 로고
    • Dopamine-based reward circuitry responsivity, genetics, and overeating
    • Stice E, Yokum S, Zald D, Dagher A. Dopamine-based reward circuitry responsivity, genetics, and overeating. Curr Top Behav Neurosci 2011, 6:81-93.
    • (2011) Curr Top Behav Neurosci , vol.6 , pp. 81-93
    • Stice, E.1    Yokum, S.2    Zald, D.3    Dagher, A.4
  • 18
    • 0029656135 scopus 로고    scopus 로고
    • Food reward: brain substrates of wanting and liking
    • 10.1016/0149-7634(95)00033-B, 8622814
    • Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev 1996, 20(1):1-25. 10.1016/0149-7634(95)00033-B, 8622814.
    • (1996) Neurosci Biobehav Rev , vol.20 , Issue.1 , pp. 1-25
    • Berridge, K.C.1
  • 19
    • 0036817344 scopus 로고    scopus 로고
    • Opioid peptides and the control of human ingestive behaviour
    • 10.1016/S0149-7634(02)00041-6, 12479844
    • Yeomans MR, Gray RW. Opioid peptides and the control of human ingestive behaviour. Neurosci Biobehav Rev 2002, 26(6):713-728. 10.1016/S0149-7634(02)00041-6, 12479844.
    • (2002) Neurosci Biobehav Rev , vol.26 , Issue.6 , pp. 713-728
    • Yeomans, M.R.1    Gray, R.W.2
  • 20
    • 2542460126 scopus 로고    scopus 로고
    • Endogenous opioids and feeding behavior: a 30-year historical perspective
    • 10.1016/j.peptides.2004.01.006, 15165728
    • Bodnar RJ. Endogenous opioids and feeding behavior: a 30-year historical perspective. Peptides 2004, 25(4):697-725. 10.1016/j.peptides.2004.01.006, 15165728.
    • (2004) Peptides , vol.25 , Issue.4 , pp. 697-725
    • Bodnar, R.J.1
  • 21
    • 3242744417 scopus 로고    scopus 로고
    • Opioids as agents of reward-related feeding: a consideration of the evidence
    • 10.1016/j.physbeh.2004.04.032, 15234591
    • Levine AS, Billington CJ. Opioids as agents of reward-related feeding: a consideration of the evidence. Physiol Behav 2004, 82(1):57-61. 10.1016/j.physbeh.2004.04.032, 15234591.
    • (2004) Physiol Behav , vol.82 , Issue.1 , pp. 57-61
    • Levine, A.S.1    Billington, C.J.2
  • 22
    • 33646889517 scopus 로고    scopus 로고
    • Cannabinoids, opioids and eating behavior: the molecular face of hedonism?
    • 10.1016/j.brainresrev.2005.10.004, 16364446
    • Cota D, Tschop MH, Horvath TL, Levine AS. Cannabinoids, opioids and eating behavior: the molecular face of hedonism?. Brain Res Rev 2006, 51(1):85-107. 10.1016/j.brainresrev.2005.10.004, 16364446.
    • (2006) Brain Res Rev , vol.51 , Issue.1 , pp. 85-107
    • Cota, D.1    Tschop, M.H.2    Horvath, T.L.3    Levine, A.S.4
  • 23
    • 0025609049 scopus 로고
    • Hyperendorphinemia in obesity is not related to the affective state
    • 10.1016/0031-9384(90)90211-L, 1964503
    • Scavo D, Barletta C, Vagiri D, Burla F, Fontana M, Lazzari R. Hyperendorphinemia in obesity is not related to the affective state. Physiol Behav 1990, 48(5):681-683. 10.1016/0031-9384(90)90211-L, 1964503.
    • (1990) Physiol Behav , vol.48 , Issue.5 , pp. 681-683
    • Scavo, D.1    Barletta, C.2    Vagiri, D.3    Burla, F.4    Fontana, M.5    Lazzari, R.6
  • 24
    • 0027967022 scopus 로고
    • Palatability of a meal influences release of beta-endorphin, and of potential regulators of food intake in healthy human subjects
    • 10.1006/appe.1994.1022, 7979341
    • Melchior JC, Rigaud D, Chayvialle JA, Colas-Linhart N, Laforest MD, Petiet A, Comoy E, Apfelbaum M. Palatability of a meal influences release of beta-endorphin, and of potential regulators of food intake in healthy human subjects. Appetite 1994, 22(3):233-244. 10.1006/appe.1994.1022, 7979341.
    • (1994) Appetite , vol.22 , Issue.3 , pp. 233-244
    • Melchior, J.C.1    Rigaud, D.2    Chayvialle, J.A.3    Colas-Linhart, N.4    Laforest, M.D.5    Petiet, A.6    Comoy, E.7    Apfelbaum, M.8
  • 25
    • 78650752631 scopus 로고    scopus 로고
    • Reward, dopamine and the control of food intake: implications for obesity
    • 10.1016/j.tics.2010.11.001, 3124340, 21109477
    • Volkow ND, Wang GJ, Baler RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn Sci 2011, 15(1):37-46. 10.1016/j.tics.2010.11.001, 3124340, 21109477.
    • (2011) Trends Cogn Sci , vol.15 , Issue.1 , pp. 37-46
    • Volkow, N.D.1    Wang, G.J.2    Baler, R.D.3
  • 26
    • 0036400336 scopus 로고    scopus 로고
    • The role of dopamine in motivation for food in humans: implications for obesity
    • 10.1517/14728222.6.5.601, 12387683
    • Wang GJ, Volkow ND, Fowler JS. The role of dopamine in motivation for food in humans: implications for obesity. Expert Opin Ther Targets 2002, 6(5):601-609. 10.1517/14728222.6.5.601, 12387683.
    • (2002) Expert Opin Ther Targets , vol.6 , Issue.5 , pp. 601-609
    • Wang, G.J.1    Volkow, N.D.2    Fowler, J.S.3
  • 28
    • 84866521972 scopus 로고    scopus 로고
    • The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study
    • 10.1016/j.comppsych.2012.02.003, 22425530
    • Ratliff JC, Palmese LB, Reutenauer EL, Liskov E, Grilo CM, Tek C. The effect of dietary and physical activity pattern on metabolic profile in individuals with schizophrenia: a cross-sectional study. Compr Psychiatry 2012, 53(7):1028-1033. 10.1016/j.comppsych.2012.02.003, 22425530.
    • (2012) Compr Psychiatry , vol.53 , Issue.7 , pp. 1028-1033
    • Ratliff, J.C.1    Palmese, L.B.2    Reutenauer, E.L.3    Liskov, E.4    Grilo, C.M.5    Tek, C.6
  • 29
    • 0038802583 scopus 로고    scopus 로고
    • Substance abuse and the heterogeneity of schizophrenia a population-based study
    • 10.1016/S0920-9964(02)00212-8, 12837529
    • Kirkpatrick B, Messias EM, Tek C. Substance abuse and the heterogeneity of schizophrenia a population-based study. Schizophr Res 2003, 62(3):293-294. 10.1016/S0920-9964(02)00212-8, 12837529.
    • (2003) Schizophr Res , vol.62 , Issue.3 , pp. 293-294
    • Kirkpatrick, B.1    Messias, E.M.2    Tek, C.3
  • 30
    • 0035185136 scopus 로고    scopus 로고
    • Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration
    • 10.1055/s-2001-18034, 11778142
    • Baptista T, Lacruz A, Angeles F, Silvera R, de Mendoza S, Mendoza MT, Hernandez L. Endocrine and metabolic abnormalities involved in obesity associated with typical antipsychotic drug administration. Pharmacopsychiatry 2001, 34(6):223-231. 10.1055/s-2001-18034, 11778142.
    • (2001) Pharmacopsychiatry , vol.34 , Issue.6 , pp. 223-231
    • Baptista, T.1    Lacruz, A.2    Angeles, F.3    Silvera, R.4    de Mendoza, S.5    Mendoza, M.T.6    Hernandez, L.7
  • 32
    • 0022195837 scopus 로고
    • Effects of long-term therapy with naltrexone on body weight in obesity
    • 10.1038/clpt.1985.197, 4042525
    • Atkinson RL, Berke LK, Drake CR, Bibbs ML, Williams FL, Kaiser DL. Effects of long-term therapy with naltrexone on body weight in obesity. Clin Pharmacol Ther 1985, 38(4):419-422. 10.1038/clpt.1985.197, 4042525.
    • (1985) Clin Pharmacol Ther , vol.38 , Issue.4 , pp. 419-422
    • Atkinson, R.L.1    Berke, L.K.2    Drake, C.R.3    Bibbs, M.L.4    Williams, F.L.5    Kaiser, D.L.6
  • 33
    • 0030965893 scopus 로고    scopus 로고
    • Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: an open study
    • 10.1016/S0006-3223(96)00523-9, 9067000
    • Zimmermann U, Rechlin T, Plaskacewicz GJ, Barocka A, Wildt L, Kaschka WP. Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: an open study. Biol Psychiatry 1997, 41(6):747-749. 10.1016/S0006-3223(96)00523-9, 9067000.
    • (1997) Biol Psychiatry , vol.41 , Issue.6 , pp. 747-749
    • Zimmermann, U.1    Rechlin, T.2    Plaskacewicz, G.J.3    Barocka, A.4    Wildt, L.5    Kaschka, W.P.6
  • 34
    • 77956904326 scopus 로고    scopus 로고
    • Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial
    • 10.1038/oby.2010.147, 20559296
    • Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O'Neil PM, Perri MG, Pi-Sunyer FX, Rock CL, Erickson JS, et al. Weight loss with naltrexone SR/bupropion SR combination therapy as an adjunct to behavior modification: the COR-BMOD trial. Obesity 2011, 19(1):110-120. 10.1038/oby.2010.147, 20559296.
    • (2011) Obesity , vol.19 , Issue.1 , pp. 110-120
    • Wadden, T.A.1    Foreyt, J.P.2    Foster, G.D.3    Hill, J.O.4    Klein, S.5    O'Neil, P.M.6    Perri, M.G.7    Pi-Sunyer, F.X.8    Rock, C.L.9    Erickson, J.S.10
  • 37
    • 0029844984 scopus 로고    scopus 로고
    • Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer
    • 10.1111/j.1530-0277.1996.tb01142.x, 8947318
    • Del Boca FK, Kranzler HR, Brown J, Korner PF. Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. Alcohol Clin Exp Res 1996, 20(8):1412-1417. 10.1111/j.1530-0277.1996.tb01142.x, 8947318.
    • (1996) Alcohol Clin Exp Res , vol.20 , Issue.8 , pp. 1412-1417
    • Del Boca, F.K.1    Kranzler, H.R.2    Brown, J.3    Korner, P.F.4
  • 38
    • 0022392593 scopus 로고
    • Riboflavin as a tracer of medication compliance
    • 10.1007/BF00870315, 4087291
    • Dubbert PM, King A, Rapp SR, Brief D, Martin JE, Lake M. Riboflavin as a tracer of medication compliance. J Behav Med 1985, 8(3):287-299. 10.1007/BF00870315, 4087291.
    • (1985) J Behav Med , vol.8 , Issue.3 , pp. 287-299
    • Dubbert, P.M.1    King, A.2    Rapp, S.R.3    Brief, D.4    Martin, J.E.5    Lake, M.6
  • 39
    • 0000503515 scopus 로고
    • The Brief Psychiatric Scale
    • Overall JE, Gorham DR. The Brief Psychiatric Scale. Psychol Rep 1962, 10(3):799-812.
    • (1962) Psychol Rep , vol.10 , Issue.3 , pp. 799-812
    • Overall, J.E.1    Gorham, D.R.2
  • 40
    • 0023606101 scopus 로고
    • The positive and negative syndrome scale (PANSS) for schizophrenia
    • 10.1093/schbul/13.2.261, 3616518
    • Kay SR, Fiszbein A, Opler LA. The positive and negative syndrome scale (PANSS) for schizophrenia. Schizophr Bull 1987, 13(2):261-276. 10.1093/schbul/13.2.261, 3616518.
    • (1987) Schizophr Bull , vol.13 , Issue.2 , pp. 261-276
    • Kay, S.R.1    Fiszbein, A.2    Opler, L.A.3
  • 41
    • 70350654728 scopus 로고
    • An inventory for measuring depression
    • 10.1001/archpsyc.1961.01710120031004, 13688369
    • Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961, 4:561-571. 10.1001/archpsyc.1961.01710120031004, 13688369.
    • (1961) Arch Gen Psychiatry , vol.4 , pp. 561-571
    • Beck, A.T.1    Ward, C.H.2    Mendelson, M.3    Mock, J.4    Erbaugh, J.5
  • 42
    • 0021989139 scopus 로고
    • The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger
    • 10.1016/0022-3999(85)90010-8, 3981480
    • Stunkard AJ, Messick S. The three-factor eating questionnaire to measure dietary restraint, disinhibition and hunger. J Psychosom Res 1985, 29(1):71-83. 10.1016/0022-3999(85)90010-8, 3981480.
    • (1985) J Psychosom Res , vol.29 , Issue.1 , pp. 71-83
    • Stunkard, A.J.1    Messick, S.2
  • 44
    • 36048945761 scopus 로고    scopus 로고
    • Validation of a scale for the assessment of food cravings among smokers
    • 10.1016/j.appet.2007.05.001, 2386855, 17574300
    • Toll BA, Katulak NA, Williams-Piehota P, O'Malley S. Validation of a scale for the assessment of food cravings among smokers. Appetite 2008, 50(1):25-32. 10.1016/j.appet.2007.05.001, 2386855, 17574300.
    • (2008) Appetite , vol.50 , Issue.1 , pp. 25-32
    • Toll, B.A.1    Katulak, N.A.2    Williams-Piehota, P.3    O'Malley, S.4
  • 45
    • 84863024553 scopus 로고    scopus 로고
    • Relationship between accelerometer-based measures of physical activity and the Yale Physical Activity Survey in adults with arthritis
    • Semanik P, Lee J, Manheim L, Dipietro L, Dunlop D, Chang RW. Relationship between accelerometer-based measures of physical activity and the Yale Physical Activity Survey in adults with arthritis. Arthritis Care Res 2011, 63(12):1766-1772.
    • (2011) Arthritis Care Res , vol.63 , Issue.12 , pp. 1766-1772
    • Semanik, P.1    Lee, J.2    Manheim, L.3    Dipietro, L.4    Dunlop, D.5    Chang, R.W.6
  • 47
    • 58149464158 scopus 로고    scopus 로고
    • Comparison of predictive equations for resting metabolic rate in obese psychiatric patients taking olanzapine
    • 10.1016/j.nut.2008.08.006, 18947974
    • Skouroliakou M, Giannopoulou I, Kostara C, Vasilopoulou M. Comparison of predictive equations for resting metabolic rate in obese psychiatric patients taking olanzapine. Nutrition 2009, 25(2):188-193. 10.1016/j.nut.2008.08.006, 18947974.
    • (2009) Nutrition , vol.25 , Issue.2 , pp. 188-193
    • Skouroliakou, M.1    Giannopoulou, I.2    Kostara, C.3    Vasilopoulou, M.4
  • 50
    • 27944511492 scopus 로고    scopus 로고
    • Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments
    • 10.1016/j.eurpsy.2005.05.009, 16139488
    • Reine G, Simeoni MC, Auquier P, Loundou A, Aghababian V, Lancon C. Assessing health-related quality of life in patients suffering from schizophrenia: a comparison of instruments. Eur Psychiatry 2005, 20(7):510-519. 10.1016/j.eurpsy.2005.05.009, 16139488.
    • (2005) Eur Psychiatry , vol.20 , Issue.7 , pp. 510-519
    • Reine, G.1    Simeoni, M.C.2    Auquier, P.3    Loundou, A.4    Aghababian, V.5    Lancon, C.6
  • 52
    • 34249333702 scopus 로고    scopus 로고
    • Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants
    • 10.1176/appi.ajp.164.7.1035, 17606655
    • Posner K, Oquendo MA, Gould M, Stanley B, Davies M. Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry 2007, 164(7):1035-1043. 10.1176/appi.ajp.164.7.1035, 17606655.
    • (2007) Am J Psychiatry , vol.164 , Issue.7 , pp. 1035-1043
    • Posner, K.1    Oquendo, M.A.2    Gould, M.3    Stanley, B.4    Davies, M.5
  • 54
    • 0025923219 scopus 로고
    • The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire
    • 10.1111/j.1360-0443.1991.tb01879.x, 1932883
    • Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO. The Fagerstrom Test for Nicotine Dependence: a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 1991, 86(9):1119-1127. 10.1111/j.1360-0443.1991.tb01879.x, 1932883.
    • (1991) Br J Addict , vol.86 , Issue.9 , pp. 1119-1127
    • Heatherton, T.F.1    Kozlowski, L.T.2    Frecker, R.C.3    Fagerstrom, K.O.4
  • 55
    • 1942536959 scopus 로고    scopus 로고
    • The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery
    • Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr Res 2004, 68(2-3):283-297.
    • (2004) Schizophr Res , vol.68 , Issue.2-3 , pp. 283-297
    • Keefe, R.S.1    Goldberg, T.E.2    Harvey, P.D.3    Gold, J.M.4    Poe, M.P.5    Coughenour, L.6
  • 56
    • 32844467558 scopus 로고    scopus 로고
    • The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome
    • 10.1080/13803390500360539, 16484097
    • Keefe RS, Poe M, Walker TM, Harvey PD. The relationship of the Brief Assessment of Cognition in Schizophrenia (BACS) to functional capacity and real-world functional outcome. J Clin Exp Neuropsychol 2006, 28(2):260-269. 10.1080/13803390500360539, 16484097.
    • (2006) J Clin Exp Neuropsychol , vol.28 , Issue.2 , pp. 260-269
    • Keefe, R.S.1    Poe, M.2    Walker, T.M.3    Harvey, P.D.4
  • 57
    • 34547145165 scopus 로고    scopus 로고
    • G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences
    • 10.3758/BF03193146, 17695343
    • Faul F, Erdfelder E, Lang AG, Buchner A. G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 2007, 39(2):175-191. 10.3758/BF03193146, 17695343.
    • (2007) Behav Res Methods , vol.39 , Issue.2 , pp. 175-191
    • Faul, F.1    Erdfelder, E.2    Lang, A.G.3    Buchner, A.4
  • 58
    • 18744366088 scopus 로고    scopus 로고
    • Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review
    • Newcomer JW. Second-generation (atypical) antipsychotics and metabolic effects: a comprehensive literature review. CNS Drugs 2005, 19(Suppl 1):1-93.
    • (2005) CNS Drugs , vol.19 , Issue.SUPPL. 1 , pp. 1-93
    • Newcomer, J.W.1
  • 59
    • 0035009791 scopus 로고    scopus 로고
    • Dropout rates in randomised antipsychotic drug trials
    • 10.1007/s002130100711, 11432684
    • Wahlbeck K, Tuunainen A, Ahokas A, Leucht S. Dropout rates in randomised antipsychotic drug trials. Psychopharmacology 2001, 155(3):230-233. 10.1007/s002130100711, 11432684.
    • (2001) Psychopharmacology , vol.155 , Issue.3 , pp. 230-233
    • Wahlbeck, K.1    Tuunainen, A.2    Ahokas, A.3    Leucht, S.4
  • 60
    • 0036942527 scopus 로고    scopus 로고
    • Predictors of noncompliance in patients with schizophrenia
    • 10.4088/JCP.v63n1206, 12523871
    • Perkins DO. Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 2002, 63(12):1121-1128. 10.4088/JCP.v63n1206, 12523871.
    • (2002) J Clin Psychiatry , vol.63 , Issue.12 , pp. 1121-1128
    • Perkins, D.O.1
  • 61
    • 0024417553 scopus 로고
    • The natural history of medication compliance in a drug trial: limitations of pill counts
    • 10.1038/clpt.1989.122, 2667837
    • Rudd P, Byyny RL, Zachary V, LoVerde ME, Titus C, Mitchell WD, Marshall G. The natural history of medication compliance in a drug trial: limitations of pill counts. Clin Pharmacol Ther 1989, 46(2):169-176. 10.1038/clpt.1989.122, 2667837.
    • (1989) Clin Pharmacol Ther , vol.46 , Issue.2 , pp. 169-176
    • Rudd, P.1    Byyny, R.L.2    Zachary, V.3    LoVerde, M.E.4    Titus, C.5    Mitchell, W.D.6    Marshall, G.7
  • 62
    • 34848852251 scopus 로고    scopus 로고
    • Best practices: surveillance and management of diabetes in a CMHC population
    • 10.1176/appi.ps.58.9.1151, 17766557
    • Srihari VH, Tek C, Chwastiak LA, Woods SW, Steiner JL. Best practices: surveillance and management of diabetes in a CMHC population. Psychiatr Serv 2007, 58(9):1151-1153. 10.1176/appi.ps.58.9.1151, 17766557.
    • (2007) Psychiatr Serv , vol.58 , Issue.9 , pp. 1151-1153
    • Srihari, V.H.1    Tek, C.2    Chwastiak, L.A.3    Woods, S.W.4    Steiner, J.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.